<?xml version="1.0" encoding="utf-8"?>
			
			<rss version="2.0" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:cc="http://web.resource.org/cc/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">

			<channel>
			<title>elizabethwhittington Blog</title>
			<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington</link>
			<description>elizabethwhittington Blog</description>
			<language>en-us</language>
			<pubDate>Sat, 21 Nov 2009 03:34:05 -0700</pubDate>
			<lastBuildDate>Tue, 10 Nov 2009 09:11:00 -0700</lastBuildDate>
			<generator>BlogCFC</generator>
			<docs>http://blogs.law.harvard.edu/tech/rss</docs>
			<managingEditor>moderator@curetoday.com (moderator)</managingEditor>
			<webMaster>moderator@curetoday.com (moderator)</webMaster>
			<itunes:subtitle></itunes:subtitle>
			<itunes:summary></itunes:summary>
			<itunes:category text="Technology" />
			<itunes:category text="Technology">
				<itunes:category text="Podcasting" />
			</itunes:category>
			<itunes:category text="Technology">
				<itunes:category text="Tech News" />
			</itunes:category>
			<itunes:keywords></itunes:keywords>
			<itunes:author></itunes:author>
			<itunes:owner>
				<itunes:email>moderator@curetoday.com</itunes:email>
				<itunes:name></itunes:name>
			</itunes:owner>
			<itunes:image href="http://www.curetoday.com/assets/images/placeholder.gif" />
			<image>
				<url>http://www.curetoday.com/assets/images/placeholder.gif</url>
				<title>elizabethwhittington Blog</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington</link>
			</image>
			<itunes:explicit>no</itunes:explicit>
			
			
			
			
			
			<item>
				<title>Season for rare lymphomas: new drug approved for CTCL</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/11/10/Season-for-rare-lymphomas-new-drug-approved-for-CTCL</link>
				<description>
				
				
				This must be the season for drug approvals for rare lymphomas--an early Christmas gift to many patients suffering from a rare blood cancer. 

Folotyn (pralatrexate), which was approved in September for peripheral T-cell lymphoma came less than one ...
				
				
				</description>
						
				
				<category>Treatment</category>				
				
				<pubDate>Tue, 10 Nov 2009 09:11:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/11/10/Season-for-rare-lymphomas-new-drug-approved-for-CTCL</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>Patients want honesty, compassion from their doctor</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/11/4/Patients-want-honesty-compassion-from-their-doctor</link>
				<description>
				
				
				Not exactly news to cancer patients, but results released today found that what patients want most out of their oncologist is honesty and compassion.

The study results were released at the annual meeting of ASTRO (American Society for Radiation On...
				
				
				</description>
						
				
				<category>General</category>				
				
				<pubDate>Wed, 04 Nov 2009 12:41:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/11/4/Patients-want-honesty-compassion-from-their-doctor</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>New smart phone application tracks cancer meds and side effects</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/10/21/New-smart-phone-application-tracks-cancer-meds-and-side-effects</link>
				<description>
				
				
				We do it when we drive, when we&apos;re at work, when we&apos;re suppose to be listening to something important ... I&apos;m sure we do it when we&apos;re getting chemo or waiting for the oncologist--talking on the phone, texting, using those many smart phone apps that ...
				
				
				</description>
						
				
				<category>General</category>				
				
				<pubDate>Wed, 21 Oct 2009 14:44:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/10/21/New-smart-phone-application-tracks-cancer-meds-and-side-effects</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>Second vaccine to prevent cervical cancer approved by FDA</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/10/16/Second-vaccine-to-prevent-cervical-cancer-approved-by-FDA</link>
				<description>
				
				
				Today, Cervarix became the second cervical cancer vaccine approved in the U.S. The FDA decided the vaccine, which is administered in three injections for females age 10 to 25, was safe and effective. It is recommended women receive the vaccine before...
				
				
				</description>
						
				
				<category>News</category>				
				
				<pubDate>Fri, 16 Oct 2009 11:59:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/10/16/Second-vaccine-to-prevent-cervical-cancer-approved-by-FDA</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>Should you be concerned about the H1N1 virus?</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/10/9/Should-you-be-concerned-about-the-H1N1-virus</link>
				<description>
				
				
				The H1N1 virus, or swine flu, has steadily swept across the country, and is considered widespread in 27 U.S. states now (view the CDC&apos;s interactive map). 

And while the virus has primarily stricken young adults, those individuals at high risk for ...
				
				
				</description>
						
				
				<category>News</category>				
				
				<pubDate>Fri, 09 Oct 2009 10:42:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/10/9/Should-you-be-concerned-about-the-H1N1-virus</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>FDA advisory panel unanimously recommends new kidney cancer drug</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/10/6/FDA-advisory-panel-unanimously-recommends-new-kidney-cancer-drug</link>
				<description>
				
				
				Update [Oct. 20]: Pazopanib gets FDA approval. Read more...

There is probably no other cancer that has seen such breakthroughs in the past five years than kidney cancer. Less than a decade ago, patients with advanced renal cell carcinoma were trea...
				
				
				</description>
						
				
				<category>News</category>				
				
				<category>Treatment</category>				
				
				<pubDate>Tue, 06 Oct 2009 09:22:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/10/6/FDA-advisory-panel-unanimously-recommends-new-kidney-cancer-drug</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>Rare lymphoma receives a much-needed drug approval</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/9/28/Rare-lymphoma-receives-drug-approval</link>
				<description>
				
				
				Folotyn (pralatrexate), a drug which made waves after results of a phase II trial were revealed at last year&apos;s American Society of Hematology meeting, was granted accelerated approval for peripheral T-cell lymphoma on Friday. (You can read more about...
				
				
				</description>
						
				
				<category>News</category>				
				
				<category>Treatment</category>				
				
				<pubDate>Mon, 28 Sep 2009 16:47:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/9/28/Rare-lymphoma-receives-drug-approval</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>Would winning a pink Vespa help you raise awareness for Breast Cancer Awareness Month?</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/9/23/Would-winning-a-pink-Vespa-help-you-raise-awareness-for-Breast-Cancer-Awareness-Month</link>
				<description>
				
				
				In addition to the ribbons, visors, golf bags, and chip clips raising awareness of National Breast Cancer Month, you may also see a few pink Vespas next month.

More than a dozen organizations are offering limited edition pink Vespas to their Breas...
				
				
				</description>
						
				
				<category>General</category>				
				
				<pubDate>Wed, 23 Sep 2009 10:23:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/9/23/Would-winning-a-pink-Vespa-help-you-raise-awareness-for-Breast-Cancer-Awareness-Month</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>Remembering Patrick Swayze</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/9/16/Remembering-Patrick-Swayze</link>
				<description>
				
				
				The news of Patrick Swayze&apos;s death on Monday night was unexpected, but not shocking. Pancreatic cancer is such a horrible disease, with a five-year survival rate of only 5 percent. The fact that he was able to work throughout much of his treatment an...
				
				
				</description>
						
				
				<category>News</category>				
				
				<pubDate>Wed, 16 Sep 2009 08:12:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/9/16/Remembering-Patrick-Swayze</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>Another news headline touting a possible cure for cancer. Yawn.</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/9/11/Another-news-headline-touting-a-possible-cure-for-cancer-Yawn</link>
				<description>
				
				
				Breaking news this morning ... another headline with &quot;cure&quot; and &quot;cancer.&quot; 

With as much excitement as I could muster, I read the opening paragraph after first noting it was a press release passed along by a news agency. A company has developed a t...
				
				
				</description>
						
				
				<category>News</category>				
				
				<pubDate>Fri, 11 Sep 2009 11:28:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/9/11/Another-news-headline-touting-a-possible-cure-for-cancer-Yawn</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>Tuning in for tonight&apos;s health care speech? Here are some interesting sites to help you prepare.</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/9/9/Tuning-in-for-tonights-health-care-speech-Do-your-homework</link>
				<description>
				
				
				I&apos;ll be the first to admit that I haven&apos;t exactly done all of my research with the health care reform debate; but let&apos;s face it, it&apos;s a pretty complicated issue.  

In doing my cram session, however, I did come across a couple of interesting finds ...
				
				
				</description>
						
				
				<category>News</category>				
				
				<pubDate>Wed, 09 Sep 2009 09:22:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/9/9/Tuning-in-for-tonights-health-care-speech-Do-your-homework</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>Zevalin approved as first-line non-Hodgkin lymphoma therapy</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/9/4/Zevalin-approved-as-firstline-nonHodgkin-lymphoma-therapy</link>
				<description>
				
				
				The approval of Zevalin (ibritumomab tiuxetan) as a first-line therapy for non-Hodgkin lymphoma was announced today. The drug was originally approved in 2002 for NHL patients whose cancer recurred or progressed after other therapies. 

The new appr...
				
				
				</description>
						
				
				<category>News</category>				
				
				<category>Treatment</category>				
				
				<pubDate>Fri, 04 Sep 2009 12:36:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/9/4/Zevalin-approved-as-firstline-nonHodgkin-lymphoma-therapy</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>The coming out of palliative care</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/8/26/The-coming-out-of-palliative-care</link>
				<description>
				
				
				A very moving and informative article in The New York Times this past week focused on palliative care--a topic many people often don&apos;t think about until it&apos;s brought up in an end-of-life situation. 

&quot;At the End, Offering Not a Cure but Comfort&quot; ma...
				
				
				</description>
						
				
				<category>General</category>				
				
				<pubDate>Wed, 26 Aug 2009 14:01:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/8/26/The-coming-out-of-palliative-care</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>The future of brain cancer therapy?</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/7/30/The-future-of-brain-cancer-therapy</link>
				<description>
				
				
				UCLA researchers have found a way to predict which brain cancers will respond to Avastin (bevacizumab), a drug recently approved for the disease (see Drugs in the News). By examining imaging scans of the brain, before Avastin is even administered, re...
				
				
				</description>
						
				
				<category>Treatment</category>				
				
				<pubDate>Thu, 30 Jul 2009 11:26:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/7/30/The-future-of-brain-cancer-therapy</guid>
				
			</item>
			
		 	
			
			
			<item>
				<title>&quot;So You Think You Can Dance&quot; shows breast cancer struggle through art</title>
				<link>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//elizabethwhittington/2009/7/24/So-You-Think-You-Can-Dance-shows-breast-cancer-struggle-through-art</link>
				<description>
				
				
				After hearing the buzz about Wednesday&apos;s show of  &quot;So You Think You Can Dance,&quot; a weekly dance competition on Fox, I had to see Melissa and Ade&apos;s contemporary dance for myself. And you&apos;re right, it moved me to tears. 

Knowing the background of the...
				
				
				</description>
						
				
				<category>General</category>				
				
				<pubDate>Fri, 24 Jul 2009 10:52:00 -0700</pubDate>
				<guid>http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/elizabethwhittington/2009/7/24/So-You-Think-You-Can-Dance-shows-breast-cancer-struggle-through-art</guid>
				
			</item>
			
		 	
			</channel></rss>